Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Urinary Bladder Neoplasms × Radiotherapy, Adjuvant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Gemcitabine 72 Cisplatin 51 pembrolizumab 24 Paclitaxel 20 Cystectomy 19 Carboplatin 18 durvalumab 17 Nivolumab 17 Docetaxel 17 atezolizumab 14 Specimen Handling 13 Radiotherapy 13 Magnetic Resonance Spectroscopy 13 avelumab 11 Mitomycin 11 Fluorouracil 11 Sunitinib 10 Doxorubicin 10 Methotrexate 9 Vinblastine 8 Filgrastim 7 Ipilimumab 6 BCG Vaccine 6 Standard of Care 5 Sorafenib 5 Radiation 5 Platinum 5 Immunoglobulin G 5 Erlotinib Hydrochloride 5 Disulfides 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡